The AACR (American Association for Cancer Research), together with the FDA and NCI, published its cancer biomarkers collaborative consensus report in an issue of Clinical Cancer Research. The report identifies eight critical areas for biomarker development—biospecimens, analytical performance, standardization and harmonization, bioinformatics, collaboration and data sharing, regulations, stakeholder education and communication, and science policy—and details 27 strategies to accelerate the translation of cancer therapeutics into the clinic by shaping the processes for the effective development of validated biomarkers and their use in clinical trials for maximum patient benefit.
http://clincancerres.aacrjournals.or...6/13/3299.full